Clinical Trial Update: Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia [Phase 4]

View source ↗

Summary

This document reports a Phase 4 clinical trial update on tandospirone in combination with atypical antipsychotic drugs for schizophrenia; current status is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Atypical antipsychotic drugs (atypical antipsychotic drugs)
• Tandospirone (tandospirone)

Snippet

Sponsor: Qingyun Yin | Conditions: Schizophrenia | Phase 4 | Status: UNKNOWN